Skip to content
Pharmaceutical Guideline

All Posts

121 articles · page 2 of 11

General

Deadline Dilemma: The Case for Extending Revised Schedule M to December 2026

As of January 2026, the Indian pharma sector faces a massive bottleneck: over 13,000 plants require inspection, yet only ~1,100 field inspectors are active. While the government has enforced Revised Schedule M, Laghu Udhyog Bharti is pushing for a vital extension until December 2026 to prevent the closure of thousands of MSMEs and ensure the continued supply of affordable medicine.

General

Essential 10 Steps for Good Manufacturing Practice in Pharmaceutical Industry

In the pharmaceutical industry, maintaining Good Manufacturing Practices (GMP) compliance is vital to ensure the safety, quality, and efficacy of pharmaceutical products. Pharmaceutical manufacturers adhere to strict guidelines to meet regulatory standards and guarantee the integrity of their operations. Let